The chemotherapy of tuberculosis--from the past to the future.
作者信息
Collazos J, Mayo J, Martínez E
机构信息
Section of Infectious Diseases, Hospital de Galdakao, Vizcaya, Spain.
出版信息
Respir Med. 1995 Aug;89(7):463-9. doi: 10.1016/0954-6111(95)90121-3.
PMID:7480975
Abstract
摘要
相似文献
1
The chemotherapy of tuberculosis--from the past to the future.结核病的化疗——从过去到未来。
Respir Med. 1995 Aug;89(7):463-9. doi: 10.1016/0954-6111(95)90121-3.
2
[Tuberculosis: reemerging disease].[结核病：再度出现的疾病]
Ann Ital Med Int. 1996 Jul-Sep;11(3):167-9.
3
[Tuberculosis in the 21st centruy].《21世纪的结核病》
Enferm Infecc Microbiol Clin. 2000 May;18(5):207-8.
4
AIDS and tuberculosis - a lethal combination.艾滋病与结核病——致命组合。
Nat Rev Microbiol. 2004 Nov;2(11):858. doi: 10.1038/nrmicro1032.
5
Molecular determinants of drug resistance in tuberculosis.结核病耐药性的分子决定因素。
Int J Tuberc Lung Dis. 2000 Feb;4(2 Suppl 1):S4-10.
6
[The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].[考虑到结核病病原体的新数据，结核病化疗中的问题]
Antibiot Khimioter. 2000;45(5):3-5.
7
Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients.艾滋病毒感染患者中耐药结核分枝杆菌的出现。
Lancet. 1991 Apr 6;337(8745):852. doi: 10.1016/0140-6736(91)92559-k.
8
9
Drug-resistant tuberculosis in AIDS.艾滋病合并耐药结核病
Chest. 1990 Feb;97(2):511-2. doi: 10.1378/chest.97.2.511a.
10
Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.耐多药结核分枝杆菌：分子视角
Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209. doi: 10.3201/eid0402.980207.
Zotero 插件